Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Metastases from Non-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06702826
What this trial is testing

Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases

Who this might be right for
Non Small Cell Lung CancerBrain MetastasesStereotactic Radiation+1 more
Rongrong Zhou 20
Testing effectiveness (Phase 2)Ended earlyNCT00280748
What this trial is testing

Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
UNC Lineberger Comprehensive Cancer Center 10
Early research (Phase 1)Study completedNCT03535363
What this trial is testing

Osimertinib With Stereotactic Radiosurgery (SRS) in Brain Metastases From EGFR Positive NSCLC

Who this might be right for
NSCLCNon-small Cell Lung Cancer
Case Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT02669914
What this trial is testing

MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors

Who this might be right for
Non-Small Cell Lung CancerNonsmall Cell Lung CancerBreast Cancer+15 more
Washington University School of Medicine 4
Testing effectiveness (Phase 2)Study completedNCT01657799
What this trial is testing

Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Brain Metastases From Non-small Cell Lung Cancer
AbbVie (prior sponsor, Abbott) 307
Early research (Phase 1)UnknownNCT03638765
What this trial is testing

Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer

Who this might be right for
Brain MetastasesLung Cancer MetastaticBreast Cancer Metastatic
Northwest Biotherapeutics 24
Early research (Phase 1)Study completedNCT00946673
What this trial is testing

Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Brain CancerNeoplasm MetastasisLung Cancer+1 more
Stanford University 17
Early research (Phase 1)Study completedNCT00884598
What this trial is testing

Cilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung Cancer

Who this might be right for
Brain and Central Nervous System TumorsLung Cancer
Universitätsmedizin Mannheim 19
Large-scale testing (Phase 3)UnknownNCT01951469
What this trial is testing

Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerBrain MetastasesEGFR Mutation
Sun Yat-sen University 160
Large-scale testing (Phase 3)Looking for participantsNCT05522660
What this trial is testing

Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerMelanoma
ETOP IBCSG Partners Foundation 180
Testing effectiveness (Phase 2)UnknownNCT01755624
What this trial is testing

Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment (COMET)

Who this might be right for
1-5 Brain Metastases From Non-Small Cell Lung Cancer
NovoCure Ltd. 18
Not applicableNot Yet RecruitingNCT07689721
What this trial is testing

CtDNA-Guided Intraventricular Therapy for CNS Malignancies

Who this might be right for
Leptomeningeal DiseaseGlioblastomaBrain Metastases+2 more
Alireza Mansouri 77
Testing effectiveness (Phase 2)Looking for participantsNCT07130786
What this trial is testing

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

Who this might be right for
SeizuresPrimary Motor CortexBrain Metastases From Non-small Cell Lung Cancer (NSCLC)+2 more
Ayal A. Aizer, MD 150
Testing effectiveness (Phase 2)UnknownNCT04905550
What this trial is testing

Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLC

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Chongqing University Cancer Hospital 50
Large-scale testing (Phase 3)UnknownNCT02972333
What this trial is testing

Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M

Who this might be right for
EGFR-TKI Resistant MutationNonsmall Cell Lung CancerAZD9291+1 more
Shandong Cancer Hospital and Institute 150
Testing effectiveness (Phase 2)WithdrawnNCT01679743
What this trial is testing

GRN1005 for Brain Metastases From Breast or Lung Cancer

Who this might be right for
Breast CancerLung NeoplasmsBreast Neoplasms+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00238251
What this trial is testing

Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases

Who this might be right for
Lung CancerMetastatic Cancer
Swiss Cancer Institute 59
Testing effectiveness (Phase 2)Study completedNCT00415363
What this trial is testing

Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy

Who this might be right for
Non Small Cell Lung CancerSmall Cell Lung Cancer
Eli Lilly and Company 109
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07789444
What this trial is testing

Sacituzumab Tirumotecan（Sac-TMT） and Brain Radotherapy for EGFR+ NSCLC With Brain Mets

Who this might be right for
Non-Small Cell Lung CancerBrain Metastases From Non-small Cell Lung Cancer (NSCLC)EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer
Xiaorong Dong 53
Not applicableActive Not RecruitingNCT07491211
What this trial is testing

Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)Brain Metastases From Non-small Cell Lung Cancer (NSCLC)Osimertinib+1 more
Fudan University 300
Next Page